Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group
- PMID: 10586170
- DOI: 10.1016/s0022-3476(99)70086-7
Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group
Abstract
Objectives: This study assessed the effects of zinc supplementation in the prevention of diarrhea and pneumonia with the use of a pooled analysis of randomized controlled trials in children in developing countries.
Study design: Trials included were those that provided oral supplements containing at least one half of the United States Recommended Daily Allowance (RDA) of zinc in children <5 years old and evaluated the prevention of serious infectious morbidity through household visits. Analysis included 7 "continuous" trials providing 1 to 2 RDA of elemental zinc 5 to 7 times per week throughout the period of morbidity surveillance and 3 "short-course" trials providing 2 to 4 RDA daily for 2 weeks followed by 2 to 3 months of morbidity surveillance. The effects on diarrhea and pneumonia were analyzed overall and in subgroups defined by age, baseline plasma zinc concentration, nutritional status, and sex. The analysis used random effects hierarchical models to calculate odds ratios (OR) and 95% CIs.
Results: For the zinc-supplemented children compared with the control group in the continuous trials, the pooled ORs for diarrheal incidence and prevalence were 0.82 (95% CI 0.72 to 0.93) and 0.75 (95% CI 0.63 to 0.88), respectively. Zinc-supplemented children had an OR of 0.59 (95% CI 0.41 to 0.83) for pneumonia. No significant differences were seen in the effects of the zinc supplement between the subgroups examined for either diarrhea or pneumonia. In the short-course trials the OR for the effects of zinc on diarrheal incidence (OR 0.89, 95% CI 0.62 to 1.28) and prevalence (OR 0.66, 95% CI 0.52 to 0.83) and pneumonia incidence (OR 0.74, 95% CI 0.40 to 1.37) were similar to those in the continuous trials.
Conclusions: Zinc supplementation in children in developing countries is associated with substantial reductions in the rates of diarrhea and pneumonia, the 2 leading causes of death in these settings.
Comment in
-
Respiratory syncytial virus and subsequent lower respiratory tract infections in developing countries: A new twist to an old virus.J Pediatr. 1999 Dec;135(6):657-61. doi: 10.1016/s0022-3476(99)70079-x. J Pediatr. 1999. PMID: 10586163 No abstract available.
-
Zinc, diarrhea, and pneumonia.J Pediatr. 1999 Dec;135(6):661-4. doi: 10.1016/s0022-3476(99)70080-6. J Pediatr. 1999. PMID: 10586164 No abstract available.
Similar articles
-
Substantial reduction in severe diarrheal morbidity by daily zinc supplementation in young north Indian children.Pediatrics. 2002 Jun;109(6):e86. doi: 10.1542/peds.109.6.e86. Pediatrics. 2002. PMID: 12042580 Clinical Trial.
-
Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria.BMC Public Health. 2011 Apr 13;11 Suppl 3(Suppl 3):S23. doi: 10.1186/1471-2458-11-S3-S23. BMC Public Health. 2011. PMID: 21501441 Free PMC article. Review.
-
Two weeks of zinc administration to Nepalese children with pneumonia does not reduce the incidence of pneumonia or diarrhea during the next six months.J Nutr. 2010 Sep;140(9):1677-82. doi: 10.3945/jn.109.117978. Epub 2010 Jul 14. J Nutr. 2010. PMID: 20631326 Clinical Trial.
-
Zinc supplementation for the prevention of acute lower respiratory infection in children in developing countries: meta-analysis and meta-regression of randomized trials.Int J Epidemiol. 2010 Jun;39(3):795-808. doi: 10.1093/ije/dyp391. Epub 2010 Feb 15. Int J Epidemiol. 2010. PMID: 20156999
-
Therapeutic and preventive effects of zinc on serious childhood infectious diseases in developing countries.Am J Clin Nutr. 1998 Aug;68(2 Suppl):476S-479S. doi: 10.1093/ajcn/68.2.476S. Am J Clin Nutr. 1998. PMID: 9701163 Review.
Cited by
-
COVID-19 pandemic: Can zinc supplementation provide an additional shield against the infection?Comput Struct Biotechnol J. 2021;19:1371-1378. doi: 10.1016/j.csbj.2021.02.015. Epub 2021 Mar 2. Comput Struct Biotechnol J. 2021. PMID: 33680350 Free PMC article. Review.
-
Prevalence of anemia and deficiency of iron, folic acid, and zinc in children younger than 2 years of age who use the health services provided by the Mexican Social Security Institute.BMC Public Health. 2007 Nov 30;7:345. doi: 10.1186/1471-2458-7-345. BMC Public Health. 2007. PMID: 18053140 Free PMC article.
-
Study Protocol for a Randomized, Double-Blind, Community-Based Efficacy Trial of Various Doses of Zinc in Micronutrient Powders or Tablets in Young Bangladeshi Children.Nutrients. 2018 Jan 26;10(2):132. doi: 10.3390/nu10020132. Nutrients. 2018. PMID: 30720778 Free PMC article.
-
Zinc treatment to under-five children: applications to improve child survival and reduce burden of disease.J Health Popul Nutr. 2008 Sep;26(3):356-65. doi: 10.3329/jhpn.v26i3.1901. J Health Popul Nutr. 2008. PMID: 18831230 Free PMC article. Review.
-
Determinants of pneumonia among under-five children at Hiwot Fana specialized hospital, Eastern Ethiopia: unmatched case-control study.BMC Pulm Med. 2023 Aug 9;23(1):293. doi: 10.1186/s12890-023-02593-3. BMC Pulm Med. 2023. PMID: 37559081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical